Firebrick Pharma Limited Stock: price and insider trades · Australia

Firebrick Pharma Limited is a Health Care company. Its directors and officers file their transactions with ASX. Over the twelve months to 18 October 2026, 3 filings were filed, from 3 insiders.

Not one open-market sale was filed. On the buying side, 2 insiders reported 2 purchases totalling €24k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. One trade stands out by size: a purchase of €16k from Peter Laurence Molloy Date of last notice 10 October 2024 Part 1 - Change of director’s relevant interests in securities In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust, disclosed on 21 May 2026. On the buying side, the filings list 2 senior executives among the declarants.

Compared with its exchange (2,527 companies, median 3 filings), a count of 3 filings is typical. Since 2026, the database holds 2 purchases and no sales by insiders of the company.

In the case of 1 purchase, another manager of the company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. The last purchase on record was published on 21 May 2026, which is 150 days ago.

Other companies in the same sector with recent insider buying flagged by our signals: Cooper Companies, Inc. and Cytosorbents Corp. These figures are compiled from regulatory filings published by ASX. They describe what insiders did and are not a recommendation.